Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	80.73M	91.21M	85.31M	107.03M	117.21M	128.31M	119.13M	134.22M	160.27M	168.41M	154.62M	172.81M	186.04M	201.27M	184.73M	200.49M	239.46M	243.78M	215.39M	261.28M
Cost of Revenue (Quarter)	14.60M	17.82M	14.72M	18.92M	22.96M	26.89M	20.78M	25.01M	32.30M	43.15M	27.48M	32.14M	42.78M	54.41M	31.99M	38.15M	59.65M	68.55M	44.51M	63.20M
Gross Profit (Quarter)	66.13M	73.40M	70.60M	88.11M	94.25M	101.42M	98.35M	109.21M	127.97M	125.26M	127.13M	140.67M	143.26M	146.86M	152.74M	162.34M	179.81M	175.23M	170.88M	198.08M
Operating items
Research & Development (Quarter)	11.74M	19.11M	17.58M	12.67M	20.47M	21.07M	22.57M	24.53M	17.50M	5.54M	27.23M	63.58M	27.58M	27.60M	34.54M	30.07M	54.96M	29.18M	69.38M	46.60M
Selling, General & Administrative (Quarter)	16.86M	18.20M	17.88M	22.16M	21.33M	22.64M	22.06M	22.81M	22.55M	27.87M	25.68M	27.22M	28.59M	28.86M	31.24M	33.92M	29.81M	57.56M	32.51M	28.05M
Other Operating Expenses (Quarter)	16.48M	7.45M	7.58M	20.16M	40.55M	10.09M	13.29M	14.97M	23.42M	51.65M	22.19M	28.51M	25.39M	34.67M	30.71M	50.16M	29.55M	49.93M	31.69M	34.12M
Operating Expenses (Quarter)	45.08M	44.77M	43.04M	54.99M	82.35M	53.81M	57.92M	62.31M	63.46M	85.06M	75.10M	119.31M	81.55M	91.13M	96.49M	114.16M	114.32M	136.67M	133.58M	108.77M
Operating Income (Quarter)	21.05M	28.63M	27.56M	33.12M	11.90M	47.61M	40.42M	46.90M	64.51M	40.20M	52.03M	21.36M	61.71M	55.73M	56.24M	48.18M	65.49M	38.56M	37.29M	89.32M
EBIT (Quarter)	21.05M	28.63M	27.56M	33.12M	11.90M	47.61M	40.42M	46.90M	64.51M	40.20M	52.03M	21.36M	61.71M	55.73M	56.24M	48.18M	65.49M	38.56M	37.29M	89.32M
Non-operating items
Interest & Investment Income (Quarter)							3.09M	3.44M	4.11M	4.10M	4.43M	4.71M	4.93M	4.48M	5.04M	5.30M	5.73M	5.85M	5.76M	7.07M
Other Non Operating Income (Quarter)	-26.15M		-0.00M	0.04M	0.06M	0.07M	0.00M	-0.03M	-9.77M		-0.14M	0.04M	-0.12M	0.16M	-0.28M	-0.19M	-0.11M	1.19M	-0.08M	0.77M
Non Operating Income (Quarter)	-5.43M	-4.19M	-4.17M	-3.93M	-3.99M	-3.58M	-2.65M	-2.78M	-2.91M
Net income details
EBT (Quarter)	-10.52M	24.48M	23.39M	29.23M	7.97M	44.10M	37.78M	44.09M	51.83M	39.69M	51.78M	21.69M	62.17M	56.16M	57.18M	49.64M	67.49M	40.76M	39.69M	93.27M
Tax Provisions (Quarter)	-0.90M	1.76M	1.90M	5.70M	-79.98M	-4.41M	8.29M	9.79M	13.37M	13.08M	13.45M	10.10M	16.08M	6.68M	11.62M	9.86M	16.62M	-24.50M	7.20M	19.59M
Profit After Tax (Quarter)	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	33.81M	38.47M	26.97M	38.33M	11.53M	46.83M	49.48M	45.74M	39.78M	50.87M	22.48M	32.49M	75.43M
Income from Continuing Operations (Quarter)	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	49.48M	45.56M	39.78M	50.87M	65.26M	32.49M	73.68M
Consolidated Net Income (Quarter)	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	49.48M	45.56M	39.78M	50.87M	65.26M	32.49M	73.68M
Income towards Parent Company (Quarter)	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	49.48M	45.56M	39.78M	50.87M	65.26M	32.49M	73.68M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	49.48M	45.56M	39.78M	50.87M	65.26M	32.49M	73.68M
Additional items
EPS (Basic) (Quarter)	-0.17	0.39	0.36	0.40	1.48	0.82	0.49	0.57	0.64	0.45	0.68	0.20	0.81	0.87	0.79	0.69	0.88	1.14	0.56	1.27
EPS (Diluted) (Quarter)	-0.17	0.38	0.35	0.39	1.44	0.79	0.48	0.56	0.63	0.44	0.67	0.20	0.79	0.85	0.78	0.68	0.87	1.11	0.55	1.25
Shares Outstanding (Quarter)	57.72M	57.53M	58.91M	59.06M	59.23M	59.17M	59.73M	59.97M	59.86M	59.47M	56.77M	56.80M	56.87M	56.89M	57.31M	57.47M	57.55M	57.49M	57.82M	57.93M
Shares Outstanding (Diluted) (Quarter)	57.72M	59.21M	60.59M	60.92M	61.21M	61.10M	61.22M	60.74M	60.68M	60.37M	57.60M	57.54M	58.10M	57.87M	58.52M	58.43M	58.72M	58.54M	58.78M	58.76M
Shares Outstanding (Entity) (Quarter)	58.41M	58.83M	59.03M	59.12M	59.30M	59.62M	59.95M	60.00M	58.57M	56.77M	56.79M	56.83M	57.03M	57.14M	57.39M	57.54M	57.60M	57.73M	57.87M	58.24M
EBITDA (Quarter)	21.05M	28.63M	27.56M	33.12M	11.90M	47.61M	40.42M	46.90M	64.51M	40.20M	52.03M	21.36M	61.71M	55.73M	56.24M	48.18M	65.49M	38.56M	37.29M	89.32M
Interest Expenses (Quarter)	18.57M	3.83M	23.84M	23.84M	23.84M	7.46M	23.84M	23.84M	23.84M	8.10M	23.84M	27.89M	72.79M	4.21M	17.88M	29.80M	17.88M	3.58M	3.32M	48.18M
Tax Rate (Quarter)	8.57%	7.20%	8.12%	19.50%	-1,003.84%	-9.99%	21.96%	22.21%	25.80%	32.96%	25.97%	46.57%	25.86%	11.90%	20.32%	19.87%	24.63%	-60.11%	18.14%	21.00%

Research Tools

Datasets

Plans

Developers

Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Research Tools

Datasets

Plans

Developers

Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Create an account

Sign In

Reset Password